Epidemiology and Control of Mansonella Perstans Infection in Uganda - Related Studies

Epidemiology and Control of Mansonella Perstans Infection in Uganda

This study has been completed.

Study NCT00215280. Last updated on April 19, 2007. Information provided by DBL -Institute for Health Research and Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Mansonelliasis
		Pruritus
		Lymphoedema
		Abdominal Pains

2	Additional conditions recognized in this trial
		Abdominal Pain
		Dipetalonema Infections
		Lymphedema

3	More general conditions related to this trial
		Filariasis
		Helminthiasis
		Lymphatic Diseases
		Nematode Infections
		Pain
		Parasitic Diseases
		Secernentea Infections
		Signs and Symptoms
		Signs and Symptoms, Digestive
		Skin Diseases
		Skin Manifestations
		Spirurida Infections

4	Interventions listed in this trial
		ivermectin and albendazole

5	Additional drug interventions recognized in this trial
		Albendazole
		Ivermectin

6	More general drug interventions related to this trial
		Anthelmintics
		Anti-Infective Agents
		Anticestodal Agents
		Antimitotic Agents
		Antineoplastic Agents
		Antiparasitic Agents
		Antiplatyhelmintic Agents
		Antiprotozoal Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		DBL -Institute for Health Research and Development
		Vector control Division, Kampala, Uganda